SHANNON CONVERY: Open Payments
NPI 1871803676 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 15 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $112 · 2025 $427
Food & beverage: $252Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $175 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Dexcom, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Novo Nordisk Inc | 1 | $26 |
| Organon LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: PROLIA, ELIQUIS, Dexcom G6 Transmitter, Wegovy, NEXPLANON, GVOKE HYPOPEN, VRAYLAR, CAMZYOS.
Industry payments across OH — which companies pay providers there.
